Aruna Gowda

712 total citations
15 papers, 516 citations indexed

About

Aruna Gowda is a scholar working on Genetics, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aruna Gowda has authored 15 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aruna Gowda's work include Chronic Lymphocytic Leukemia Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Aruna Gowda is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Aruna Gowda collaborates with scholars based in United States, Canada and India. Aruna Gowda's co-authors include John C. Byrd, Myron S. Czuczman, Francisco J. Hernandez‐Ilizaliturri, Joy Knight, Petr Starostik, Scott H. Olejniczak, Julie P. Deans, Amy Lehman, Carolyn Cheney and Michael A. Caligiuri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aruna Gowda

14 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aruna Gowda United States 8 263 231 222 186 119 15 516
Joy Knight United States 8 290 1.1× 288 1.2× 181 0.8× 154 0.8× 113 0.9× 13 633
JK Larsen Denmark 12 227 0.9× 102 0.4× 254 1.1× 196 1.1× 28 0.2× 17 448
Elena Ruíz-Ballesteros Spain 8 299 1.1× 164 0.7× 211 1.0× 96 0.5× 22 0.2× 8 468
Nancy Whiting United States 10 123 0.5× 463 2.0× 74 0.3× 283 1.5× 230 1.9× 18 683
RM Braziel United States 4 330 1.3× 221 1.0× 156 0.7× 53 0.3× 27 0.2× 5 434
Martin F. M. de Rooij Netherlands 7 400 1.5× 153 0.7× 539 2.4× 229 1.2× 42 0.4× 9 663
Gavin Babbage United Kingdom 6 254 1.0× 142 0.6× 242 1.1× 154 0.8× 82 0.7× 9 433
Davide Bagnara Italy 12 164 0.6× 106 0.5× 253 1.1× 345 1.9× 96 0.8× 29 511
L. Escribano Spain 7 139 0.5× 73 0.3× 205 0.9× 292 1.6× 19 0.2× 11 537
Margot Jak Netherlands 8 116 0.4× 149 0.6× 209 0.9× 199 1.1× 47 0.4× 23 394

Countries citing papers authored by Aruna Gowda

Since Specialization
Citations

This map shows the geographic impact of Aruna Gowda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aruna Gowda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aruna Gowda more than expected).

Fields of papers citing papers by Aruna Gowda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aruna Gowda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aruna Gowda. The network helps show where Aruna Gowda may publish in the future.

Co-authorship network of co-authors of Aruna Gowda

This figure shows the co-authorship network connecting the top 25 collaborators of Aruna Gowda. A scholar is included among the top collaborators of Aruna Gowda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aruna Gowda. Aruna Gowda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Riess, Jonathan W., Mary W. Redman, Paul Wheatley‐Price, et al.. (2021). A phase II study of rucaparib in patients with high genomic LOH and/or BRCA 1/2 mutated stage IV non-small cell lung cancer (Lung-MAP Sub-Study, S1900A).. Journal of Clinical Oncology. 39(15_suppl). 9024–9024. 8 indexed citations
2.
Gowda, Aruna, et al.. (2018). PREPARTUM CERVICO-VAGINAL PROLAPSE IN AMRITHMAHAL COW – A CASE REPORT. SHILAP Revista de lepidopterología.
3.
4.
Lapalombella, Rosa, Aruna Gowda, Trupti Joshi, et al.. (2009). The humanized CD40 antibody SGN‐40 demonstrates pre‐clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. British Journal of Haematology. 144(6). 848–855. 32 indexed citations
5.
6.
Czuczman, Myron S., Scott H. Olejniczak, Aruna Gowda, et al.. (2008). Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both GlobalCD20Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels. Clinical Cancer Research. 14(5). 1561–1570. 181 indexed citations
7.
Roda, Julie M., Aruna Gowda, Rehan M. Hussain, et al.. (2007). IL-21 Promotes Apoptosis through Induction of the BH3 Only Protein Bim and Enhacnes Direct and Innate Immune-Promoted Death of Chronic Lymphocytic Leukemia Cells.. Blood. 110(11). 3118–3118. 1 indexed citations
8.
Gowda, Aruna, Asha Ramanunni, Carolyn Cheney, et al.. (2007). IL-21 enhances chemoimmunotherapy mediated death of chronic lymphocytic leukemia cells. Journal of Clinical Oncology. 25(18_suppl). 7094–7094. 1 indexed citations
9.
Lapalombella, Rosa, Trupti Joshi, Carolyn Cheney, et al.. (2007). Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood. 110(7). 2569–2577. 99 indexed citations
10.
Gowda, Aruna & John C. Byrd. (2006). Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia. Current Opinion in Internal Medicine. 5(5). 498–504. 19 indexed citations
11.
Zhao, Xiaobin, Trupti Joshi, Rosa Lapalombella, et al.. (2006). NK Cells Contribute Significantly to the Innate Immune Effector Role of CD37-Specific SMIP in CLL and NHL.. Blood. 108(11). 135–135. 5 indexed citations
12.
13.
Gowda, Aruna, et al.. (2004). Hypersensitivity Reactions to oxaliplatin: incidence and management.. PubMed. 18(13). 1671–5; discussion 1676, 1680, 1683. 54 indexed citations
14.
Hernandez‐Ilizaliturri, Francisco J., Aruna Gowda, & Myron S. Czuczman. (2004). Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.. PubMed. 2(9). 606–18. 5 indexed citations
15.
Czuczman, Myron S., Scott H. Olejniczak, Aruna Gowda, Petr Starostik, & Francisco J. Hernandez‐Ilizaliturri. (2004). Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Structural Changes in the Internal Domain of CD20 Regulated at the Post-Transcriptional Level.. Blood. 104(11). 2280–2280. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joy Knight Breakdown of academic impact, for papers by JK Larsen Breakdown of academic impact, for papers by Elena Ruíz-Ballesteros Breakdown of academic impact, for papers by Nancy Whiting Breakdown of academic impact, for papers by RM Braziel Breakdown of academic impact, for papers by Martin F. M. de Rooij Breakdown of academic impact, for papers by Gavin Babbage Breakdown of academic impact, for papers by Davide Bagnara Breakdown of academic impact, for papers by L. Escribano Breakdown of academic impact, for papers by Margot Jak
Rankless by CCL
2026